OOIR: Observatory of International Research

Papers

(The H4-Index of Human Vaccines & Immunotherapeutics is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Factors influencing COVID-19 vaccination intention among overseas and domestic Chinese university students: a cross-sectional survey	339
Assessment of caregiver willingness to vaccinate their children against COVID-19 in Saudi Arabia: a cross-sectional study	300
Evaluation of immunogenicity after first dose of hepatitis B vaccine in newborns with very low birth weight	263
Letter to the editor in response to: Rotavirus vaccine administration patterns in Italy: potential impact on vaccine coverage, compliance and adherence	147
Temporary vaccination clinic for COVID-19 in Zhuhai, China	130
Plasma therapy: a passive resistance against the deadliest	123
Vaccine manufacturing is essential to ensure access	122
HV&I Reviewer Highlight	101
Antibody-dependent passive protection of mucosal surfaces	92
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance	76
Acceptability of COVID-19 vaccine in the working-age population in Shanghai city: a cross-sectional study	76
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality	72
Improving Tdap maternal immunization rate in Saudi Arabia	67
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons	66
Harnessing live vectors for cancer vaccines: Advancing therapeutic immunotherapy	61
Correction	61
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children	59
Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges	59
Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention	59
Factors influencing COVID-19 vaccine acceptance and hesitancy: Correspondence	58
Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’	57
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam	57
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control	56
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China	54
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children	53

Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study	53
Human vaccines & immunotherapeutics: News October 2022	52
Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children	51
Leapfrogging with technology: introduction of a monitoring platform to support a large-scale Ebola vaccination program in Rwanda	49
COVID-19 vaccine acceptance and hesitancy among ethnic minorities in Hong Kong	49
Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States	46
Human vaccines & immunotherapeutics: news October 2021	45
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector	45
Human vaccines & immunotherapeutics news: July 2020	45
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial	45
Epidemiological characteristics and trends of Bacillus Calmette–Guérin lymphadenitis in Shanghai, China from 2010 to 2019	43
Adjuvants: friends in vaccine formulations against infectious diseases	42
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary	42
Acute encephalitis after COVID-19 vaccination: A case report and literature review	42
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling	41
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer	40
Human vaccines and immunotherapeutics: News December 2023	40
Comment on the “Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao’an district of She	40